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Background: Laparoscopic radical prostatectomy (LRP) is a challenging technique that is associated with
a steep learning curve. We describe a novel technique to develop bladder neck traction using a Foley
catheter during extraperitoneal LRP to enhance bladder neck dissection, thereby improving patient and
procedural outcomes.
Materials and methods: The novel technique employed a four-trocar approach to prostatectomy, which
involved the introduction of a 1-0 Vicryl suture into the extraperitoneal space using an Endo Close needle
to pull up the Foley catheter tip and make the bladder neck prominent. From June 2006 to November
2012, clinicopathological data of 71 patients who underwent four-port extraperitoneal LRP (modiﬁed
extraperitoneal LRP, Group 1) were assessed and compared with those from 22 patients who underwent
transperitoneal LRP (Group 2) retrospectively.
Results: The two groups were comparable in terms of pathological staging and Gleason score. The
operative time was signiﬁcantly shorter (p < 0.05) and the total blood loss was less in Group 1 patients
(p < 0.05). No patient in either group underwent early reintervention for bleeding or blood transfusion.
Bilateral or unilateral nerve sparing surgery was performed in 80.3% and 45.5% of Group 1 and Group 2
patients, respectively. The immediate, 1 month, 3 month, 6 month, and 1 year continence rates were,
respectively, 19.7%, 38%, 69%, 91.5%, and 100% in Group 1 and 18.2%, 50.0%, 77.3%, 86.4%, and 95.5% in
Group 2. In Group 1, 100% of patients were continent 12 months postprocedure. The potency rate was
71.4% in both groups.
Conclusion: Improved bladder neck enhancement provides a clearer vision during bladder neck
dissection. Similar functional results and cancer control rates were also encountered during modiﬁed
extraperitoneal radical prostatectomy. This novel technique is a feasible method for performing endo-
scopic radical prostatectomy using four ports instead of ﬁve.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Potential surgical treatments for patients with localized prostate
cancer include retropubic radical prostatectomy, laparoscopic
radical prostatectomy (LRP), and robotic-assisted LRP. The gold
standard for operative intervention in patients with localized
prostate cancer remains retropubic radical prostatectomy, which
was adopted by Walsh et al1 in 1980. LRP was ﬁrst performed inDa Hospital, Number 1, Yida
82445, Taiwan.
).
ciation. Published by Elsevier Taiw1992 by Schuessler et al2 In 1997 they reported the initial short-
term experience of nine cases, and concluded that the procedure
was feasible but offered no advantage over retropubic radical
prostatectomy.2 However, Guillonneau et al3 and Abbou et al4
standardized the LRP technique, and concluded that it resulted in
better visual accuracy and more precise dissection. Extraperitoneal
LRP (ELRP) was ﬁrst reported by Raboy et al5 in 1997; they subse-
quently reported the use of ELRP as an effective operative choice in
1998.6 During LRP, bladder neck dissection, preservation of the
neurovascular bundle, and urethrovesical anastomosis are the most
time-consuming procedures. To facilitate the LRP procedure, we
adopted a novel strategy in 2009 to facilitate bladder neck dissec-
tion and decrease the operative time. In the current study, we
compared modiﬁed ELRP with LRP, and evaluated the oncologicalan LLC. Open access under CC BY-NC-ND license.
Fig. 1. Trocar map. At points aec, 11-mm trocars were inserted and at point d a 5 mm
trocar was inserted.
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tertiary referral center.
2. Materials and methods
This study was a retrospective review of the clinical and path-
ological data of 102 patients diagnosed with prostate cancer who
accepted treatment using preperitoneal LRP. One surgeon per-
formed all surgeries in a single institution between June 2006 and
November 2012. We included patients with clinical organ-conﬁned
prostate cancer who had undergone limited pelvic lymph node
dissection; the minimal follow-up period was 9 months. Patients
were excluded if pathology reports showed that the tumor had
invaded the bladder, pelvic wall, or the levator ani muscles. A total
of 102 cases were enrolled in the study initially, among which nine
were excluded due to advanced pathological stage. Of the 93
remaining cases, 71 underwent ELRP with four ports (modiﬁed
ELRP group; Group 1). These patients were compared retrospec-
tively with 22 patients (Group 2) who underwent transperitoneal
LRP. Preoperative parameters [age, body mass index, serum
prostate-speciﬁc antigen (PSA), Gleason score, and clinical stage],
operative parameters (operation time, estimated blood loss, and
nerve sparing), and postoperative parameters [prostate weight,
Gleason score, pathology stage (T and N), surgical margins, and PSA
(at 2 weeks, 1.5 months, 3 months, 6 months, 9 months, and 12
months)] were recorded. Furthermore, we also followed the
freedom from biochemical recurrence (an elevated PSA of >0.05 ng/
dL), the continence rate (not requiring the use of protective pads),
and the potency rate (a self-reported erection sufﬁcient to achieve
intercourse with or without the use of a phosphodiesterase type 5
inhibitor).
2.1. Patient preparation and positioning
The preoperative workup included a complete biochemical
proﬁle, complete blood counts, a chest X-ray, a bone scan, and
either computed tomography or magnetic resonance imaging to
exclude metastatic disease. After inducing general anesthesia, two
inﬂatable air tourniquet cuffs were placed beneath the back of the
patient. Next, the patient was placed in the lithotomy position. All
bony prominences and weight-bearing sites were well padded and
protected to avoid muscular injury. The chest, shoulders, and thighs
were secured to the operating table using straps. Cautionwas taken
to prevent the patients from sliding off the table when they were
turned during the different operative procedures.
2.2. Trocar mapping
2.2.1. Group 1
An extraperitoneal laparoscopic technique was used. First, a 1.2-
cm infraumbilical incisionwas made, which split the linea alba and
rectus muscle to ﬁnd the posterior rectal muscle sheath. A balloon
dilatation trocar was used to smoothly explore the preperitoneal
space. After a blunt dissection of the preperitoneal space, the ﬁrst
11-mm trocar (Double Success Co. Ltd, Taipei, Taiwan) was inserted
at the infraumbilical region approximately 14 cm above the pubic
bone (Fig. 1, point a), which served as a camera port. The next two
11-mm trocars (Double Success Co. Ltd, Taipei,Taiwan) (Fig. 1,
points b and c) were placed just lateral to the rectus abdominis
muscle on the right and left sides, and 2e4 cm inferior to the
umbilicus. One 5-mm trocars (Fig. 1, point d) were placed off the
anterior iliac spine on the right and left sides. A four-port retro-
peritoneal laparoscopic technique was used, with the patient in the
mild Trendelenburg position. The trocar map is shown in Fig. 1.2.2.2. Group 2
The ﬁrst 11-mm trocar was placed at the level of the
infraumbilicus using an open technique. We used a 0 lens (Stryke,
USA) throughout the procedure and inspected the abdominal
cavity after placing the ﬁrst trocar. The next two 11-mm trocars
were placed just lateral to the rectus abdominis muscle on the
right and left sides and 2e4 cm inferior to the umbilicus. Finally,
two 5-mm trocars were placed off the anterior iliac spine on the
right and left sides. Therefore, a total of ﬁve ports were used
during the procedure.2.3. Operative method
2.3.1. Group 1
The preperitoneal fat was excised using LigaSure forceps to
properly identify the prostate gland. Next the bilateral endopel-
vic fascia was incised, and the dorsal-vein complex was sutured
and ligated using a CT-1 needle and a 1-0 Vicryl thread. The
bladder neck was incised using monopolar cautery to expose the
Foley catheter. Next, a fascia needle with a 1-0 Vicryl ﬁlament
was inserted into the extraperitoneal space 1 cm above the pubic
bone (Fig. 2A). The Foley catheter was pulled up along with the
ﬁlament to enhance the bladder neck (Fig. 2B). The bladder neck
was then transected using monopolar cautery and LigaSure for-
ceps. The neurovascular bundle was preserved in antegrade, ac-
cording to both the tumor location and the dissection status.
Bilateral limited lymph node dissection was performed over the
obturator fossae. The bladder neck was reconstructed using 2-
0 chromic catgut. Urethrovesical anastomosis was performed
using an interrupted suture with both an RB1 needle and a 2-
0 Vicryl thread. Next, a 20 Fr three-way Foley catheter was
inserted into the bladder for drainage, followed by inﬂation with
a 20 mL balloon.2.3.2. Group 2
We used the transperitoneal LRP technique described by Guil-
lonneau and Vallancien,3 which involved initial dissection of the
vasa and seminal vesicles. The anastomosis was fashioned using an
interrupted RB1 needle and a 2-0 Vicryl thread.
Fig. 2. (A) Fascial needle insertion site, about 1 cm above the pubic bone. (B) The Foley catheter was pulled up along with the ﬁlament to enhance the bladder neck in modiﬁed
extraperitoneal laparoscopic radical prostatectomy.
Table 1
Preoperative data.
Group 1 Group 2
No. of patients 71 22
Age (y) 69.3 ± 16.9 71.2 ± 6.3
Body mass index (kg/m2) 24.6 ± 2.8 24.2 ± 2.2
Preop total PSA (ng/mL) 15.39 ± 13.39 19.5 ± 23.08
Clinical stage
cT1 28 (39.4) 9 (40.9)
cT2 29 (40.8) 8 (36.4)
cT3 14 (19.7) 5 (22.7)
cT4 0 0
Biopsy (Gleason score) 6.78 ± 0.43 6.18 ± 0.4
Data are presented as n (%) or mean ± SD.
Group 1 ¼ modiﬁed extraperitoneal laparoscopic radical prostatectomy; Group
2 ¼ transperitoneal laparoscopic radical prostatectomy; PSA ¼ prostate-speciﬁc
antigen; SD ¼ standard deviation.
Table 2
Peri- and postoperative data.
Group 1 Group 2
No. of patients 71 22
Operative time (min) 184.3 ± 46.3* 285.9 ± 77.6*
Total blood loss (mL) 183.0 ± 133.1* 276.1 ± 148.4*
Specimen weight (g) 48.3 ± 22.0 50.1 ± 22.2
Pathologic stage
pT0 1 (1.4) 2 (9.1)
pT2 53 (74.6) 11 (50.0)
pT3 17 (23.9) 9 (40.9)
Pathological Gleason score 6.9 ± 0.2 7.1 ± 0.2
Nerve sparing rate 57/71 (80.3) 10/22 (45.5)
Duration of catheterization (d) 7.8 8.8
Data are presented as n (%) or mean ± SD.
* Statistical signiﬁcance.
Group 1 ¼ modiﬁed extraperitoneal laparoscopic radical prostatectomy; Group
2 ¼ transperitoneal laparoscopic radical prostatectomy.
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Table 4
Continence rate of functional outcome.
Immediate 1 mo 3 mo 6 mo 12 mo
Group 1 13/71 (19.7) 27/71 (38.0) 49/71 (69.0) 65/71 (91.5) 71/71 (100)
Group 2 4/22 (18.2) 11/22 (50) 18/22 (77.3) 19/22 (86.4) 21/22 (95.5)
Data are presented as N/n (%).
Group 1 ¼ modiﬁed extraperitoneal laparoscopic radical prostatectomy; Group
2 ¼ transperitoneal laparoscopic radical prostatectomy.
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Statistical analyses were performed using t tests to compare
continuous variables. Analyses showed minimal statistical signiﬁ-
cance, deﬁned using p < 0.05. Patient clinical data were stored in a
database and analyzed using 2010 Microsoft Excel software.
3. Results
The preoperative and operative data are shown in Tables 1 and
2, respectively. Themean agewas 69.3 years (range 56e84 years) in
Group 1 and 71.2 years (range 56e85 years) in Group 2. The mean
preoperative PSAvalues in Groups 1 and 2 were 15.39 ng/mL (range
2.09e83.6 ng/mL) and 19.5 ng/mL (range 4.87e99.2 ng/mL),
respectively. The mean operative times in Groups 1 and 2 were 184
minutes (range 80e350minutes) and 286 minutes (range 175e395
minutes), respectively. The mean blood loss was 183.0 mL (range
50e500 mL) in Group 1 and 276.1 mL (range 50e500 mL) in Group
1. Weights of the prostate and seminal vesicles in Groups 1 and 2
were 48.3 g (range 19e124 g) and 50.1 g (range 12.5e105 g),
respectively. No open conversion was noted in the patients. The
nerve sparing rates were 80.3% and 45.5% in Groups 1 and 2,
respectively. In Group 2, the pathological stage was T0 in two cases,
T2 in 11 cases, and T3 in nine cases. In Group 1, the pathology stage
was T0 in one case, T2 in 53 cases, and T3 in 17 cases. The mean
duration of catheterization was 7.8 days in Group 1 and 8.8 days in
Group 2. The positive surgical margin (PSM) rates in Groups 1 and 2
were 18.5% (10/54) and 23.1% (3/13) for pT2 tumors, and 23.5% (4/
17) and 66.7% (6/9) for pT3 tumors, respectively. Transient stress
urinary incontinence was noted in most patients, except for 13 in
Group 1 and four in Group 2. In Group 1, 38% (27/71) of patients
were continent 1 month later, 91.5% (65/71) 6 months later, and
100% (71/71) 12 months later. In Group 2, 50% (11/22) of patients
were continent 1 month later, 86.4% (19/22) 6 months later, and
95.5% (21/22) 12 months later. The recovery of continence was
similar between the groups. Approximately 84.5% (60/71) of the
patients in Group 1 maintained nadir PSA levels during follow-up,
compared with 68.2% (15/22) in Group 2. There were 42 patients
(35 in Group 1 and 7 in Group 2) with documented changes in
sexual function before and after surgery; nerve sparing was per-
formed on either one side or both sides in these patients. The total
potency rate in Groups 1 and 2 was 71.4% (25/35 and 5/7, respec-
tively; Tables 3 and 4).
4. Discussion
The current gold standard treatment for localized prostate
cancer is radical retropubic prostatectomy. Although ELRP has been
performed since 1997, it remains a technique under development.
We try to minimize the intraoperative morbidities such as trans-
peritoneal side effects during radical prostatectomy in ELRP
without compromising either tumor outcome or function.7,8 After
creating a surgical space under directed visual guidance, peritonealTable 3
Cancer control and functional outcome.
Nadir level
of PSA
Nerve sparing
rate
Continence
rate (1 y)
Potency rate
Group 1 60/71 (84.5) 57/71 (80.3) 71/71 (100) 25/35 (71.4)
Group 2 15/22 (68.2) 10/22 (45.5) 21/22 (95.5) 5/7 (71.4)
Data are presented as N/n (%).
Group 1 ¼ modiﬁed extraperitoneal laparoscopic radical prostatectomy; Group
2 ¼ transperitoneal laparoscopic radical prostatectomy; PSA ¼ prostate-speciﬁc
antigen.injury can be prevented easily. If the inferior epigastric vessel is
injured, coagulation can be performed using LigaSure. In this study,
we introduced a modiﬁed method for bladder neck traction to
enhance the bladder neck during dissection. The operative time
was shorter for patients who underwent the novel procedure
(Group 1) compared with those in Group 2 (184.3 minutes vs. 285.9
minutes, p < 0.05). Rozet et al8 and Stolzenburg et al9 reported
similar operative times: 173 minutes in 600 cases and 150.7 mi-
nutes in 2400 cases, respectively. The treatment procedure used in
Group 1 provided better vision during bladder neck dissection,
thereby allowing us to complete the surgery with a similar efﬁ-
ciency to that in other high-volume centers. Eden et al10 also
concluded that ELRP is superior to transperitoneal LRP in terms of
operative time, hospitalization, and early continence. They re-
ported similar operative times of 190.6 minutes versus 184.3 mi-
nutes for ELRP and modiﬁed ELRP, respectively. In the modiﬁed
method, Foley catheter traction provided a possible choice for
achieving bladder neck dissection and reducing the number of
working ports (from 5 to 4). It also provided a steadier bladder neck
without the need for additional grasping during bladder neck
dissection. A shorter operation time may signiﬁcantly reduce blood
loss during the operation (in this study, Group 1 vs. Group 2:
184 mL vs. 286 mL; p < 0.05).
The effectiveness of LRP was reported in several large series
with PSM rates of 6.2e27.5% for pT2 tumors and 31.1e68.0% for pT3
tumors. In the largest ELRP series (2400 cases reported by Stol-
zenburg et al9), the PSM rate was 8% for pT2 and 35.6% for pT3
cancers. In the current study, the PSM rates in Groups 1 and 2 were
18.5% (10/54) and 23.1% (3/13) for pT2 tumors and 23.5% (4/17) and
66.7% (6/9) for pT3 tumors, respectively. Because of the progressing
pathology in Group 2, a higher PSM rate was noted compared with
Group 1 [40.9% (9/22) vs. 23.9% (17/71)]. The 3-year recurrence-free
survival rates in previous studies were 72e88%.11,12 In one midterm
result of a series of 1115 ELRP procedures, the overall PSA
recurrence-free survival rate was 84% after 3 years.13 Furthermore,
the PSA recurrence-free survival after ELRP in a study in Taiwan
performed by Tai et al14 revealed 3- and 5-year PSA recurrence-free
survival rates of 82.1% and 74.5%, respectively. The PSA recurrence-
free survival rate for patients in Group 1 was 84.5% during follow-
up compared with 68.2% in Group 2. Table 5 shows a comparison of
the continence outcomes with deﬁnitions of no pad use and similar
continence rates between groups immediately after the removal of
the Foley catheter, and 1 month, 3 months, 6 months, and 12
months postprostatectomy. Similar observations had been reported
previously by Patel et al15 and Ou et al.16 The potency rates usingTable 5
Continence rate.
Immediate 1 mo 3 mo 6 mo 12 mo
Group 1 19.7 38.0 69.0 91.5 100
Patel et al15 d 47 82 89 98
Ou et al16 20 d 76.7 96.7 100
Data are presented as %.
Group 1 ¼ modiﬁed extraperitoneal laparoscopic radical prostatectomy.
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year.16e18 Nerve preservation was performed in all patients with
documented preoperative potency, and the potency rate after 1
year was 71.4%. For the continence and potency results, we did not
use validated questionnaires to assess the outcome; they were
instead determined primarily by the physician. There was a high
degree of correlation between the physician- and patient-reported
continence assessments when the deﬁnition was pad-free status.
There was a similar correlation in the self-reported potency, which
was derived from the International Index of Erectile Function.18
Therefore, our results did not over- or under-report patient
outcomes.
4.1. Limitations
There are several limitations to the current study, including the
small number of cases and the retrospective nature of the study. In
addition, only a single surgeon performed all the operations. It is
possible that an increasing number of surgeons performing modi-
ﬁed ELRP will result in the reporting of much more convincing
clinical data compared with previously reported articles.
5. Conclusion
The improved bladder neck enhancement provided clearer
vision during bladder neck dissection. Adequate functional results
and cancer control rates were also achieved during the modiﬁed
ELRP. This novel technique provides a feasible method for per-
forming endoscopic radical prostatectomy effectively using four
ports instead of ﬁve.
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